Varian acquires maker of patient monitoring system

The radiation therapy company said the buy expands its motion-management portfolio, part of its cancer care strategy.

By Susan Kelly • Aug. 7, 2018

AI-based medical imaging market on track to hit $2B by 2023

Major applications are expected in neurology and cardiovascular disease detection and diagnosis, according to a report from Signify Research.

By Meg Bryant • Aug. 3, 2018

Drugs make up more US health spending than thought, report suggests

Research published in Health Affairs finds drugs accounted for 15% of total U.S. healthcare spending in 2016, higher than the oft-cited 10% figure.

By Ned Pagliarulo • Aug. 3, 2018

Cerner bookings, revenue see strong growth in Q2

Seven large transactions contributed more than $75 million to bookings, with Cerner President Zane Burke calling the deals "a full box of chocolates ... all very desirable." 

By Meg Bryant • Aug. 3, 2018

Bio-Techne closes $250M Exosome Diagnostics takeover

The acquisition moves the company into the nascent liquid biopsy sector.

By Nick Paul Taylor • Aug. 3, 2018

Hologic buys Faxitron for $85M to expand breast cancer business

The takeover moves Hologic deeper into the breast conserving surgery market.

By Nick Paul Taylor • Aug. 2, 2018

CSI, Aerolase partner on laser atherectomy device

St. Paul, Minnesota-based CSI competes in the market against much bigger players including Medtronic, Boston Scientific and Phillips.

By Susan Kelly • Aug. 1, 2018

Stryker says Q2 tops goals, will stick to M&A playbook

The device maker boasted of strong demand for its robot for knee surgery but said its spine business remained "challenged."

By Susan Kelly • July 25, 2018

Quest Diagnostics posts slight Q2 revenue miss

CEO Stephen Rusckowski said the company welcomes CMS' recent proposal to change how it collects clinical laboratory fee data.

By Susan Kelly • July 24, 2018

Tendyne investors sue Abbott over lost milestone payment

After the success of transcatheter aortic valve replacement therapy, device companies are now focusing efforts on minimally invasive procedures to replace the mitral valve. 

By Susan Kelly • July 23, 2018

Boston Scientific to buy Claret Medical for $220M

The device giant was impressed by the effectiveness of Claret's device in reducing the incidence of strokes during TAVR procedures and the opportunity for other future uses.

By David Lim • July 20, 2018

Medical device connectivity market could exceed $1B by 2022

The widespread adoption of EHRs is driving fast growth, according to a new analysis.

By Meg Bryant • July 17, 2018

J&J says medical device sales improve in second quarter

CEO Alex Gorsky told investors on a conference call the company is "very interested in value creating inorganic growth opportunities in medical devices."

By Susan Kelly • July 17, 2018

Stryker names new president, tweaks leadership structure

Timothy Scannell will take over effective next month. The 28-year company veteran had been group president for the MedSurg and Neurotechnology businesses for nearly a decade.  

By Susan Kelly • July 11, 2018

Healthcare startups raise $15B across 779 deals in first half of year

June was a slow month, however, with investments down 3% from the prior year, according to a Pitchbook analysis for Forbes.

By Meg Bryant • July 10, 2018

Boston Scientific buys atrial fibrillation device maker for $200M

The company has been an investor in Cryterion since 2016 and the deal gives it the roughly 65% remaining stake it does not already own.  

By Susan Kelly • July 9, 2018

Amazon's medical supply chain ambitions: 4 things to know

“Online channel[s are] going to be the primary marketplace[s] for even the most premium of medical devices in the future,” Amazon's global healthcare leader Chris Holt told Healthcare Dive.

By Rebecca Pifer • July 6, 2018

Digital health funding sets new H1 record with $3.4B across 193 deals

The sustained growth reflects the sector’s maturation along with a healthy venture ecosystem, a new Rock Health report says. However, despite bullish investment in digital health startup, exits have been slow. 

By Meg Bryant • July 3, 2018

Novartis to spin out Alcon into standalone device company

After months of weighing its options, the Swiss pharma is focusing in on therapeutics and shedding its ophthalmology device business. 

By Lisa LaMotta • June 29, 2018

GE to spin off healthcare unit in latest restructuring

Moody's and investors applauded the move, which comes amid a reboot of the health division.

By Meg Bryant • June 27, 2018

Blockbuster digital health funding to spill to 2018

"There will be an effort to look more closely at the impact on health outcomes and cost savings and not just 'is this a cool idea?'" says Chilmark Research's Brian Eastwood.

By Jeff Byers , Meg Bryant , Shannon Muchmore • Jan. 4, 2018

New alliance aims to advance digital therapeutics

Founding members include Akili Interactive, Propeller Health, Voluntis and WellDoc.

By Meg Bryant • Oct. 27, 2017

Digital health funding hits annual high of $4.7B at end of Q3

The sector continues to shift to a business-to-business strategy.

By Meg Bryant • Oct. 3, 2017